Literature DB >> 2659269

Oral shigella vaccines.

T L Hale, S B Formal.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2659269     DOI： 10.1007/978-3-642-74529-4_22

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  3 in total

Review 1.  Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations.

Authors:  D T O'Hagan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

2.  Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine.

Authors:  V I Levenson; T P Egorova; Z P Belkin; V G Fedosova; J L Subbotina; E Z Rukhadze; E K Dzhikidze; Z K Stassilevich
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

3.  Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.

Authors:  D N Taylor; A C Trofa; J Sadoff; C Chu; D Bryla; J Shiloach; D Cohen; S Ashkenazi; Y Lerman; W Egan
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.